![Eric Hyllengren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hyllengren
Keine laufenden Positionen mehr
Vermögen: 185 155 $ am 31.05.2026
Profil
Eric Hyllengren worked as Executive Director-Business Development at Amgen, Inc. from 2017 to 2018.
Mr. Hyllengren worked as Chief Financial, Operating & Accounting Officer at Atara Biotherapeutics, Inc. from 2024 to 2025.
Mr. Hyllengren worked as Chief Financial & Accounting Officer at Zura Bio Ltd. from 2025 to 2026.
Mr. Hyllengren completed undergraduate studies at the University of Notre Dame and earned an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 17’617 ( 0.2% ) | 185 155 $ | 31.05.2026 |
Ehemalige bekannte Positionen von Eric Hyllengren
| Unternehmen | Position | Ende |
|---|---|---|
| ZURA BIO LIMITED | Finanzdirektor/CFO | 20.04.2026 |
| ATARA BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 31.03.2025 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Eric Hyllengren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Wählen Sie MarketScreener 
